Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap

NACompletedINTERVENTIONAL

Enrollment

2,912

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

End Stage Renal Disease (ESRD)

Interventions

DEVICE

ClearGuard HD end cap

The ClearGuard HD End Cap elutes chlorhexidine acetate into the hemodialysis catheter hub

Trial Locations (1)

Frenova Renal Research, Waltham

All Listed Sponsors

collaborator

Fresenius Medical Care North America

INDUSTRY

lead

Pursuit Vascular, Inc.

INDUSTRY

NCT02604264 - Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap | Biotech Hunter | Biotech Hunter